The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic analysis of driver-negative lung adenocarcinoma (LA) in lifetime never smokers.
 
Aline Fusco Fares
No Relationships to Disclose
 
Sebastiao N. Martins-Filho
No Relationships to Disclose
 
Quan Li
No Relationships to Disclose
 
Andrew Seto
No Relationships to Disclose
 
Erin L. Stewart
Employment - Pentavere
 
Tong Zhang
No Relationships to Disclose
 
Sally CM Lau
No Relationships to Disclose
 
Deepti Ravi
No Relationships to Disclose
 
Jessica Weiss
No Relationships to Disclose
 
Devalben Patel
No Relationships to Disclose
 
Nhu-An Pham
No Relationships to Disclose
 
Adrian G. Sacher
Honoraria - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech/Roche; KisoJi Biotechnology; Merck; Pfizer; Tesaro
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Genentech/Roche; KisoJi Biotechnology; Merck; Pfizer
Research Funding - AstraZeneca; Genentech/Roche
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; GlaxoSmithKline; Gritstone Bio; Pfizer
 
Penelope Ann Bradbury
Honoraria - Abbvie; Lilly; Merck
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim
 
Tracy Stockley
No Relationships to Disclose
 
Natasha B. Leighl
Consulting or Advisory Role - Xcovery
Research Funding - Array BioPharma (Inst); Guardant Health (Inst); Novartis (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Nektar; Roche
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Merck Serono; Merck Sharp & Dohme; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck Serono
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merrimack (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Ming Sound Tsao
Honoraria - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Merck; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Merck; Pfizer; Roche Canada; Takeda
Research Funding - AstraZeneca (Inst); Bayer (Inst); Merck Sharp & Dohme (Inst)
 
Geoffrey Liu
Honoraria - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Merck; novartis; pfizer; Roche Canada; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; novartis; pfizer; Roche Canada; takeda
Speakers' Bureau - AstraZeneca; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); roche (Inst); Takeda